Wang Gang, Zhu Jian, Liu LiPeng
School of Clinical Medicine, Tsinghua University, Beijing, China.
Department of Rheumatology and Immunology, Beijing Tsinghua Changgung Hospital, Beijing, China.
Immunopharmacol Immunotoxicol. 2022 Feb;44(1):I-X. doi: 10.1080/08923973.2021.2001498. Epub 2021 Nov 15.
We, the authors, Editors and Publisher of , have retracted the following article: Gang Wang, Jian Zhu & LiPeng Liu. Curcumin deactivates M2 macrophages to alleviate lung fibrosis in IgG4-related disease through activating the toll-like receptor 9 pathway. Published online: 15 Nov 2021. https://doi.org/10.1080/08923973.2021.2001498Since publication, the authors noted there are serious concerns with the reliability of the published results. The positive results in Figure 1 in the article could not be reproduced when the test was repeated. This means that curcumin has not been proven to treat pulmonary fibrosis caused by IgG4-related diseases.The authors alerted the Editor and Publisher to the problems, and all have agreed to retract the article to ensure the integrity of the scholarly record. The authors apologise for this error.We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as 'Retracted'.
我们,本文的作者、编辑及出版商,撤回以下文章:王钢、朱健、刘立鹏。姜黄素通过激活Toll样受体9通路使M2巨噬细胞失活以减轻IgG4相关疾病中的肺纤维化。在线发表于:2021年11月15日。https://doi.org/10.1080/08923973.2021.2001498自文章发表以来,作者注意到已发表结果的可靠性存在严重问题。重复试验时,文章中图1的阳性结果无法重现。这意味着姜黄素尚未被证明可治疗IgG4相关疾病引起的肺纤维化。作者将这些问题告知了编辑和出版商,各方均同意撤回文章以确保学术记录的完整性。作者为此错误表示歉意。我们在决策过程中参考了我们的出版道德与诚信政策以及COPE关于撤稿的指南。撤回的文章将继续在线发布以保留学术记录,但每页都将添加“已撤回”的数字水印。